Trial
NCT00623168
Ribavirin for Hemorrhagic Fever With Renal Syndrome
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
U.S. Army Medical Research and Development Command
Collaborators
—
Condition
Hemorrhagic Fever With Renal Syndrome
Intervention
Ribavirin
Why stopped
This was an expanded access treatment protocol that did not enroll any subjects due to no infections requiring treatment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-27